Spring Discovery
Spring Discovery is a privately held, Palo Alto-based biotech founded in 2017 that applies data-driven discovery methods to develop therapies targeting the biological processes of aging itself, serving the longevity therapeutics market.
- Company typePrivate
- Founded2017
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Spring Discovery firmographics
Firmographics- Name
- Spring Discovery
- Website
- https://springdiscovery.com
- Company type
- Private
- Founded year
- 2017
- Headcount range
- 11–50 employees
- Short description
- Spring Discovery is a privately held, Palo Alto-based biotech founded in 2017 that applies data-driven discovery methods to develop therapies targeting the biological processes of aging itself, serving the longevity therapeutics market.
- Ownership category
- akta.pro rank
Spring Discovery industry classification
Industry- Product category
- Aging Therapeutics Discovery / Longevity Biotechnology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where Spring Discovery is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Markets served
Spring Discovery business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Spring Discovery product offering
Product offeringCore offering
Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself. The company combines biology, data science, and decision science to identify and prioritize therapeutic targets, supporting partners in the development of treatments for age-related diseases. Its work is centered on translating aging biology into actionable, druggable programs.
Differentiator
Problem solved
Functional benefit
Products and services
- Aging Biology Therapeutic Target Discovery
Companies that use Spring Discovery
Customer profileIdeal customer profiles2 records
Spring Discovery technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Spring Discovery competitors and assessment
Company assessmentDirect peers
- BioAge Labs: Biotech using AI to discover therapeutics that target the biology of aging, with clinical-stage programs. Most direct peer given shared mission of AI-enabled aging therapeutics discovery.
- Retro Biosciences: Longevity biotech developing therapies that target hallmarks of aging, combining cellular reprogramming and AI-driven biology. Direct peer in aging-therapeutics discovery.
- Juvenescence: Longevity-focused biotech developing and partnering on therapeutics that target aging mechanisms. Comparable as a longevity therapeutics platform operator.
- NewLimit: Longevity company developing epigenetic-reprogramming therapeutics to treat age-related disease. Comparable as an early-stage aging-target discovery platform with strong computational bent.
- Insilico Medicine: AI-native drug discovery company with a longevity focus, combining generative biology, chemistry, and clinical development. Comparable to Spring Discovery in using ML to accelerate target identification and therapeutic design across age-related diseases.
- Unity Biotechnology: Public longevity biotech developing senolytic therapies for age-related disease. Direct comparable as an aging-biology therapeutic platform with similar target modalities.
Emerging players
- Schrödinger: Physics-based computational platform for drug discovery and materials science. Adjacent comparable as a software-enabled molecular discovery platform with a SaaS-licensing business model.
- Recursion Pharmaceuticals: AI-driven drug discovery platform combining high-throughput biology with ML. Comparable as a techbio with similar target-discovery and platform-licensing model.
Broad incumbents
- Calico Life Sciences: Alphabet-backed longevity company pursuing fundamental biology of aging to develop therapeutics. Broader incumbent in the same mission space with vastly more resources.
- Altos Labs: Well-capitalized (>$3B raised) cell-rejuvenation and longevity therapeutics company. Broader incumbent pursuing similar aging-biology therapeutic mission with greater capital and headcount.
Market position
Customer concentration
Spring Discovery social profiles
Digital presenceSpring Discovery financial estimates
Financial estimateRevenue estimate
Valuation estimate
Spring Discovery leadership team
Management profileNumber of profiles
Profiles4 records
Spring Discovery funding detail
Funding detailFunding overview
Funding rounds4 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Spring Discovery M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Spring Discovery
What does Spring Discovery do?
Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself. The company combines biology, data science, and decision science to identify and prioritize therapeutic targets, supporting partners in the development of treatments for age-related diseases. Its work is centered on translating aging biology into actionable, druggable programs.
When was Spring Discovery founded?
Spring Discovery was founded in 2017. It employs 11 to 50 people.
Where is Spring Discovery based?
Spring Discovery is headquartered in Palo Alto, United States, in the North America region.
Who are Spring Discovery's main competitors?
Direct peers on record are BioAge Labs, Retro Biosciences, Juvenescence, NewLimit, Insilico Medicine and Unity Biotechnology. Emerging players are Schrödinger and Recursion Pharmaceuticals. Broad incumbents are Calico Life Sciences and Altos Labs.
Does Spring Discovery have an API?
No public API is recorded for Spring Discovery.
What industry is Spring Discovery in?
Spring Discovery's product category is Aging Therapeutics Discovery / Longevity Biotechnology. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 541714 and its SIC code is 8731.